This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Genticel. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: **The Innovations of Etienne Joly: A Pioneer in Chimeric Proteins**
Introduction
Etienne Joly, an accomplished inventor based in Fourquevaux, France, has made significant contributions to the field of biotechnology. With a focus on immunology and protein engineering, he has been awarded two patents that showcase his innovative approach to the development of chimeric proteins.
Latest Patents
One of Etienne Joly's latest patents involves the invention of CyaA-based chimeric proteins comprising a heterologous polypeptide and their applications in the induction of immune responses. The patent describes a chimeric protein that consists of three key components arranged from N-terminal to C-terminal: (a) a N-terminal part of a CyaA protein, (b) a heterologous polypeptide, and (c) a C-terminal part of a CyaA protein. This invention also includes a polynucleotide encoding a deleted version of CyaA, as well as a polynucleotide that encodes the chimeric protein itself. Furthermore, the patent encompasses compositions that include at least one chimeric protein and outlines the prophylactic and therapeutic uses of these compositions.
Career Highlights
Etienne Joly's dedication to innovation in biotechnology has earned him recognition within his field. He is affiliated with Genticel, where he continues to drive research and development in chimeric proteins. His work represents a fusion of advanced molecular biology and practical applications in medicine, particularly in the context of immunological responses.
Collaborations
Throughout his career, Etienne Joly has collaborated with notable professionals in the field, including colleagues such as Yolande Misseri and Michael Esquerre. These partnerships have contributed to the advancement of his research and the successful commercialization of his inventions.
Conclusion
Etienne Joly's contributions to the biotechnology industry, particularly through his patented innovations in chimeric proteins, highlight the importance of interdisciplinary collaboration and innovative thinking. His work not only exemplifies the spirit of invention but also promises to enhance immunotherapeutic strategies, paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile